Careers
Contact
India flag iconIndiaUSA flag iconUSAGreat Britain flag iconUKSouth Africa flag iconSouth AfricaAustralia flag iconAustraliaPhilippines flag iconPhilippinesGermany flag iconGermanyNetherlands flag iconNetherlandsMexico flag iconMexicoBrazil flag iconBrazilCanada flag iconCanadaSwitzerland flag iconSwitzerland
Integrated Annual Report - Lupin
Integrated Annual Report - Lupin
ShareholderInformation
Stock Exchange IntimationsAGM, Postal Ballot, and EGMShareholding PatternShare PriceRatingsDividendUnclaimed Dividend and SharesEmployee Stock Option SchemesImportant Communication for ShareholdersInvestor FAQsInvestor Contacts

Stock Exchange Intimations

Search
Update on acquisition of VISUfarma B.V., the NetherlandsAcquisition of Multicare Pharmaceuticals Philippines, IncPress Release- Completion of Acquisition of VISUfarmaCertificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 Q4_FY26Press Release-Earned Great Place To Work® Certification for 2026-27Press Release- Approval of Dapagliflozin Tablets in the U.SPress Release- Approval of Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets in the U.SGrant of Stock Options under ESOP SchemesPress Release- Launches of Dapagliflozin Tablets in the U.SSettlement Agreement with Humana Inc
Product Finder